en
svPress releases
Press release 2020-03-27
Trading in Xspray Pharma’s shares commences today on Nasdaq Stockholm
Regulatory press release 2020-03-26
Bulletin from the extraordinary general meeting of Xspray Pharma AB (publ)
Regulatory press release 2020-03-26
The conditions for Xspray Pharma’s listing on Nasdaq Stockholm have been fulfilled
Regulatory press release 2020-03-23
Xspray Pharma publishes prospectus in connection with its listing on Nasdaq Stockholm
Regulatory press release 2020-03-18
Xspray Pharma approved for listing on Nasdaq Stockholm
Regulatory press release 2020-03-17
Xspray receives notification of manufacturing approval and provides update on clinical studies
Regulatory press release 2020-02-28
Xspray Pharma publishes Interim report Q4, January – December 2019
Regulatory press release 2020-02-24
Notice of extraordinary general meeting of Xspray Pharma AB (publ)
Press release 2020-02-18
Three additional product patents in the US for HyNap-Dasa
Press release 2020-02-12